PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
70.18%
Revenue growth above 1.5x ENPH's 10.30%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
111.14%
Gross profit growth above 1.5x ENPH's 7.89%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
444.77%
Positive EBIT growth while ENPH is negative. John Neff might see a substantial edge in operational management.
1553.08%
Positive operating income growth while ENPH is negative. John Neff might view this as a competitive edge in operations.
656.87%
Positive net income growth while ENPH is negative. John Neff might see a big relative performance advantage.
580.95%
Positive EPS growth while ENPH is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
580.95%
Positive diluted EPS growth while ENPH is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.19%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
0.05%
Slight or no buyback while ENPH is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
946.34%
Positive OCF growth while ENPH is negative. John Neff would see this as a clear operational advantage vs. the competitor.
792.23%
Positive FCF growth while ENPH is negative. John Neff would see a strong competitive edge in net cash generation.
12104.02%
10Y CAGR of 12104.02% while ENPH is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
678.10%
5Y CAGR of 678.10% while ENPH is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
229.29%
3Y CAGR of 229.29% while ENPH is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
11014.38%
OCF/share CAGR of 11014.38% while ENPH is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
70160.74%
OCF/share CAGR of 70160.74% while ENPH is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
820.71%
3Y OCF/share CAGR of 820.71% while ENPH is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
1219.73%
10Y net income/share CAGR of 1219.73% while ENPH is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
5895.86%
Net income/share CAGR of 5895.86% while ENPH is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
2361.57%
3Y net income/share CAGR of 2361.57% while ENPH is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
56.12%
Equity/share CAGR of 56.12% while ENPH is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
51.21%
Equity/share CAGR of 51.21% while ENPH is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.95%
AR growth of 76.95% while ENPH is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
9.65%
Inventory growth of 9.65% while ENPH is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
16.18%
Asset growth of 16.18% while ENPH is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
16.24%
BV/share growth of 16.24% while ENPH is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
43.49%
Debt growth of 43.49% while ENPH is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
5.33%
R&D dropping or stable vs. ENPH's 11.75%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
53.53%
SG&A growth well above ENPH's 15.38%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.